What's new?

Added 3 hours ago Drug news

FDA expands approval for KardiaMobile to include bradycardia and tachycardia detection.- AliveCor

AliveCor announced two additional FDA 510(k)-cleared indications, making KardiaMobile the only consumer ECG device in the world with FDA-clearance to...

Added 3 hours ago Drug news

Five-year study shows SRT-100 benefits patients with non-melanoma skin cancer/- Sensus Healthcare

Sensus Healthcare announced topline results from a five-year retrospective study of non-melanoma skin cancer (NMSC) patients treated with Superficial Radiation...

Added 3 hours ago Drug news

FDA approves TransPyloric Shuttle device for obesity.- BAROnova

BAROnova announced that the FDA has approved the TransPyloric Shuttle (TPS) Device, a non-surgical weight loss solution for adult individuals...

Added 1 day ago Drug news

Keytruda and Inlyta approved by FDA to treat first line renal cell carcinoma

Merck Inc., announced that the FDA has approved Keytruda, Merck’s anti-PD-1 therapy, in combination with Inlyta (axitinib), a tyrosine kinase...

Added 1 day ago Drug news

Successful COAST-X Phase III study of Taltz for the treatment of non-radiographic axial spondyloarthritis

Eli Lilly and Company announced that Taltz (ixekizumab) met the primary and all major secondary endpoints in COAST-X, a Phase...